Drug Patent Expirations for Oct 20, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

BELBUCA (buprenorphine hydrochloride)
Endo Pharms Inc
Patent number: 6,159,498
Expiration Date: Oct 18, 2016

BUNAVAIL (buprenorphine hydrochloride; naloxone hydrochloride)
Biodelivery Sci Intl
Patent number: 6,159,498
Expiration Date: Oct 18, 2016

ONSOLIS (fentanyl citrate)
Biodelivery Sci Intl
Patent number: 6,159,498
Expiration Date: Oct 18, 2016

VISTOGARD (uridine triacetate)
Wellstat Therap
Patent number: 5,968,914
Expiration Date: Oct 19, 2016

AGGRASTAT (tirofiban hydrochloride)
Medicure
Patent number: 5,965,581
Expiration Date: Oct 23, 2016

AGGRASTAT (tirofiban hydrochloride)
Medicure
Patent number: 5,733,919
Expiration Date: Oct 23, 2016

AGGRASTAT (tirofiban hydrochloride)
Medicure
Patent number: 5,972,967
Expiration Date: Oct 23, 2016

DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.

For more information try a trial

Click here for reuse options!
Copyright 2016 Biotechblog

Leave a Reply

%d bloggers like this: